Tuesday, December 23, 2025
Home Tags Zydus Lifesciences

Tag: Zydus Lifesciences

Zydus Lifesciences Limited signs an exclusive agreement with Myriad Genetics of US to launch cancer-risk assessment diagnostic tests in India
Brands in Conversation

Zydus Lifesciences Limited signs an exclusive agreement with Myriad Genetics of US to launch cancer-risk assessment diagnostic tests in India

Author -
0
Zydus and Formycon enter into an Exclusive Partnership for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab), in US and Canada
Collaboration & Partnerships

Zydus and Formycon enter into an Exclusive Partnership for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab), in US and Canada

Author -
0
Zydus receives final approval from USFDA for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial
Announcement &Achievement

Zydus receives final approval from USFDA for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial

Passionate in Marketing -
0
Zydus receives final approval from USFDA for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial
Announcement &Achievement

Zydus receives final approval from USFDA for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial

Passionate in Marketing -
0
Zydus’ Amplitude receives CE mark for its robotic surgical system ‘Andy’
Announcements & Achievements

Zydus’ Amplitude receives CE mark for its robotic surgical system ‘Andy’

Passionate in Marketing -
0
Zydus receives USFDA Orphan Drug Designation (ODD) for Desidustat for the treatment of beta-thalassemia
Health/ Lifestyle & Entertainment

Zydus receives USFDA Orphan Drug Designation (ODD) for Desidustat for the treatment of beta-thalassemia

Author -
0
Zydus receives NOC from Health Canada for ZDS-Varenicline Tablets 0.5 &1 mg
Industry & Sector-Specific

Zydus receives NOC from Health Canada for ZDS-Varenicline Tablets 0.5 &1 mg

Author -
0
Zydus receives final approval from USFDA for Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg
Brands in Conversation

Zydus receives final approval from USFDA for Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg

Author -
0
Zydus Gets Exclusive Licensing Rights For Next Gen Immuno-Oncology Platforms From The Us Based Agenus
Health/ Lifestyle & Entertainment

Zydus Gets Exclusive Licensing Rights For Next Gen Immuno-Oncology Platforms From The Us Based Agenus

Author -
0
Zydus to enter global biologics CDMO business Plans to acquire Agenus’ U.S. manufacturing facilities to accelerate development of innovative therapies
Business & Finance

Zydus to enter global biologics CDMO business Plans to acquire Agenus’ U.S. manufacturing facilities to accelerate development of innovative therapies

Author -
0
12Page 1 of 2

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

Passionate in Marketing is promoted by i-miRa Knowledge Solutions, a company founded in 2010 to foster various business units dedicated to creating, disseminating, and managing knowledge-based products, services, and solutions. These offerings cater to corporate entities, startups, and academic institutions alike.

Contact : [email protected]

FOLLOW US

© 2025| Passionate In Marketing |All Rights Reserved | Privacy Policy